Dentsply Sirona Is Maintained at Overweight by Morgan Stanley
Dentsply Sirona Analyst Ratings
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Cuts Target Price to $23
Mizuho Initiates Coverage On Dentsply Sirona With Neutral Rating, Announces Price Target of $21
Dentsply Sirona Is Maintained at Buy by UBS
Dentsply Sirona Analyst Ratings
UBS Lowers Price Target on DENTSPLY SIRONA to $27 From $35, Keeps Buy Rating
Stifel Nicolaus Remains a Hold on DENTSPLY SIRONA (XRAY)
J.P. Morgan Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $24
A Quick Look at Today's Ratings for Dentsply Sirona(XRAY.US), With a Forecast Between $20 to $30
Dentsply Sirona Is Maintained at Outperform by Barrington Research
Dentsply Sirona Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: AMN Healthcare Services (AMN), DENTSPLY SIRONA (XRAY) and Haemonetics (HAE)
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Cuts Target Price to $30
Baird Maintains Neutral on Dentsply Sirona, Lowers Price Target to $24
DENTSPLY SIRONA: Buy Rating Amid 2024 Challenges and Strategic Outlook for Recovery
Leerink Partners Downgrades Dentsply Sirona(XRAY.US) to Hold Rating
Dentsply Sirona Analyst Ratings
Evercore Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $27
DENTSPLY SIRONA (XRAY) Gets a Buy From Evercore ISI